Golam M Shameem
Examiner (ID: 5274, Phone: (571)272-0706 , Office: P/1626 )
Most Active Art Unit | 1626 |
Art Unit(s) | 1621, 1626, 1622 |
Total Applications | 3085 |
Issued Applications | 2242 |
Pending Applications | 305 |
Abandoned Applications | 538 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18345200
[patent_doc_number] => 20230133310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => MORINGA PEREGRINA SEED EXTRACT RICH IN 2,5-DIFORMYLFURAN, PROCESS FOR OBTAINING SAME AND USE THEREOF IN COSMETIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/633380
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633380 | None | May 20, 2021 | Issued |
Array
(
[id] => 18345200
[patent_doc_number] => 20230133310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => MORINGA PEREGRINA SEED EXTRACT RICH IN 2,5-DIFORMYLFURAN, PROCESS FOR OBTAINING SAME AND USE THEREOF IN COSMETIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/633380
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633380 | None | May 20, 2021 | Issued |
Array
(
[id] => 18398144
[patent_doc_number] => 11660259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Magnolia extract containing compositions
[patent_app_type] => utility
[patent_app_number] => 17/326109
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14209
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17326109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/326109 | Magnolia extract containing compositions | May 19, 2021 | Issued |
Array
(
[id] => 17154881
[patent_doc_number] => 20210315932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
[patent_app_type] => utility
[patent_app_number] => 17/323664
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/323664 | Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products | May 17, 2021 | Pending |
Array
(
[id] => 18003523
[patent_doc_number] => 20220362289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => ANTI-GLYCATION COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/319446
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319446 | Anti-glycation compositions | May 12, 2021 | Issued |
Array
(
[id] => 17911194
[patent_doc_number] => 20220313589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => MANUFACTURING METHOD FOR COSMETIC COMPOSITION OF FUCOIDAN AND COSMETIC COMPOSITION COMPRISING LOW MOLECULAR WEIGHT FUCOIDAN USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/318573
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318573 | Manufacturing method for cosmetic composition of fucoidan and cosmetic composition comprising low molecular weight fucoidan using the same | May 11, 2021 | Issued |
Array
(
[id] => 18003370
[patent_doc_number] => 20220362136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => USE OF EXTRACT OF AQUILARIA MALACCENSIS SEED IN PREPARATION OF SKIN CARE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/316739
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/316739 | USE OF EXTRACT OF AQUILARIA MALACCENSIS SEED IN PREPARATION OF SKIN CARE COMPOSITION | May 10, 2021 | Abandoned |
Array
(
[id] => 17050702
[patent_doc_number] => 20210260136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => Compositions and Methods for Treating Multiple Sclerosis and Related Disorders
[patent_app_type] => utility
[patent_app_number] => 17/316303
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316303
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/316303 | Compositions and Methods for Treating Multiple Sclerosis and Related Disorders | May 9, 2021 | Abandoned |
Array
(
[id] => 18978833
[patent_doc_number] => 11903987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Artificial compositions comprising corosolic acid, oleanolic acid; and ursolic acid in a form of an emulsion, salve, ointment, suspension, or gel
[patent_app_type] => utility
[patent_app_number] => 17/314110
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 29
[patent_no_of_words] => 9734
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314110 | Artificial compositions comprising corosolic acid, oleanolic acid; and ursolic acid in a form of an emulsion, salve, ointment, suspension, or gel | May 6, 2021 | Issued |
Array
(
[id] => 19241080
[patent_doc_number] => 12011496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Topical macqui berry formulation
[patent_app_type] => utility
[patent_app_number] => 17/306203
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17547
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306203
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/306203 | Topical macqui berry formulation | May 2, 2021 | Issued |
Array
(
[id] => 17377072
[patent_doc_number] => 11235061
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-02-01
[patent_title] => Topical solubilized ivermectin for inflammatory skin conditions
[patent_app_type] => utility
[patent_app_number] => 17/228077
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3348
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228077
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228077 | Topical solubilized ivermectin for inflammatory skin conditions | Apr 11, 2021 | Issued |
Array
(
[id] => 17322565
[patent_doc_number] => 11213551
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-01-04
[patent_title] => Ocular treatment compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/222379
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8624
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222379 | Ocular treatment compositions and methods of use thereof | Apr 4, 2021 | Issued |
Array
(
[id] => 17593548
[patent_doc_number] => 20220143121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => THERAPEUTIC TREATMENT FOR THE CORONAVIRUS DISEASE COVID-19
[patent_app_type] => utility
[patent_app_number] => 17/602234
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602234
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602234 | THERAPEUTIC TREATMENT FOR THE CORONAVIRUS DISEASE COVID-19 | Mar 31, 2021 | Abandoned |
Array
(
[id] => 17895392
[patent_doc_number] => 20220305054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => FOODS TO PROMOTE BETTER HEALTH AND/OR TO MAINTAIN HOMEOSTAIS AND METHOD OF PRODUCTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/214346
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214346
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214346 | Foods to promote better health and/or to maintain homeostasis and method of production thereof | Mar 25, 2021 | Issued |
Array
(
[id] => 17050704
[patent_doc_number] => 20210260138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => BEE VENOM NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/210397
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210397
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210397 | Bee venom nanoparticles | Mar 22, 2021 | Issued |
Array
(
[id] => 18116363
[patent_doc_number] => 11547735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Composition for ameliorating psoriasis symptoms containing extract of
[patent_app_type] => utility
[patent_app_number] => 17/205468
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 19
[patent_no_of_words] => 4805
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/205468 | Composition for ameliorating psoriasis symptoms containing extract of | Mar 17, 2021 | Issued |
Array
(
[id] => 18634917
[patent_doc_number] => 11759488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Use of antrodia cinnamomea for increasing alcohol metabolism
[patent_app_type] => utility
[patent_app_number] => 17/203145
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 5828
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203145 | Use of antrodia cinnamomea for increasing alcohol metabolism | Mar 15, 2021 | Issued |
Array
(
[id] => 18187617
[patent_doc_number] => 11578187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Natural crystalline colorant and process for production
[patent_app_type] => utility
[patent_app_number] => 17/201978
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 8562
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201978 | Natural crystalline colorant and process for production | Mar 14, 2021 | Issued |
Array
(
[id] => 17095425
[patent_doc_number] => 20210283216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => Antiviral Pharmaceutical Compositions and Method of Manufacturing
[patent_app_type] => utility
[patent_app_number] => 17/198015
[patent_app_country] => US
[patent_app_date] => 2021-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198015
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198015 | Antiviral pharmaceutical compositions and method of manufacturing | Mar 9, 2021 | Issued |
Array
(
[id] => 16961589
[patent_doc_number] => 20210213088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => INHIBITOR OF INFLAMMATORY CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/192133
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/192133 | Inhibitor of inflammatory conditions | Mar 3, 2021 | Issued |